Halabi, S., Kelly, W. K., Zhou, H., Armstrong, A. J., Quinn, D., Fizazi, K., … Small, E. J. (2014). The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials. In Journal of Clinical Oncology (Vol. 32, pp. 5002–5002). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.5002

Halabi, Susan, William Kevin Kelly, Haojin Zhou, Andrew J. Armstrong, David Quinn, Karim Fizazi, Nicole C. Solomon, et al. “The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials.” In Journal of Clinical Oncology, 32:5002–5002. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.5002.

Halabi S, Kelly WK, Zhou H, Armstrong AJ, Quinn D, Fizazi K, et al. The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 5002–5002.

Halabi, Susan, et al. “The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 5002–5002. Crossref, doi:10.1200/jco.2014.32.15_suppl.5002.

Halabi S, Kelly WK, Zhou H, Armstrong AJ, Quinn D, Fizazi K, Solomon NC, Tannock I, Petrylak DP, Morris MJ, Small EJ. The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 5002–5002.